PDCD1 and metastatic melanoma: Finally, a 62-year-old Caucasian woman, patient 3, with metastatic melanoma treated with anti-PD-1 and with an immune unconfirmed progressive disease (iUPD) as the best response, after 4 weeks of immunotherapy developed psoriasis (PASI 15) and discontinued ICI treatment for this ircAE.